Index Constituent Change - SYGH

SYGNIA ITRIX COLLECTIVE INVESTMENT SCHEME
Sygnia Itrix Solactive Healthcare 150 ETF
JSE Code: SYGH
ISIN: ZAE000300521


A portfolio in the Sygnia Itrix Collective Investment Scheme in
Securities, registered as such in terms of the Collective Investment
Schemes Control Act, 45 of 2002.

INDEX CONSTITUENT CHANGE - SYGH

In terms of section 19.28 of the JSE Limited Listings Requirements,
notice is hereby given to investors of the above ETF securities that
the following changes in the constituents of the underlying index in
the table below is effective from 02 November 2023
.

The following constituents have been added to SYGH:

ISIN           Share Name               Previous Weight  New Weight

BMG762791017 ROIVANT SCIENCES LTD       0.00%            0.07%
US28414H1032 ELANCO ANIMAL HEALTH INC   0.00%            0.06%


The following constituents have been removed from SYGH:

                                                
ISIN           Share Name                       Previous      New
                                                Weight        Weight

US92338C1036   VERALTO CORP                     0.22%         0.00%
CH1243598427   SANDOZ GROUP AG                  0.15%         0.00%
US03753U1060   APELLIS PHARMACEUTICALS INC      0.07%         0.00%
KYG8167W1380   SINO BIOPHARMACEUTICAL LTD ORD   0.06%         0.00%


The above gave affect to changes in the index constituent weights.
The portfolio composition file can be viewed at www.sygnia.co.za/etfs/etf-and-etn-fund-range.

03 November 2023

Manager
Sygnia Itrix (RF) Pty Limited


JSE Sponsors
Vunani Sponsors

Date: 03-11-2023 11:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.